Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,634Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Takecab

02 3Takecab/Vocinti

PharmaCompass

01

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharmaceutical Sciences
Not Confirmed

Brand Name : Takecab

arrow
Pharmaceutical Sciences
Not Confirmed

Vonoprazan Fumarate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 647

2018 Revenue in Millions : 535

Growth (%) : 21

blank

02

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

03

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

04

Brand Name : Takecab/Vocinti

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

Brand Name : Takecab/Vocinti

arrow
Pharma Summit
Not Confirmed

Vonoprazan Fumarate

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2022 Revenue in Millions : 837

2021 Revenue in Millions : 837

Growth (%) : 0

blank

05

Brand Name : Takecab/Vocinti

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

Brand Name : Takecab/Vocinti

arrow
Pharma Summit
Not Confirmed

Vonoprazan Fumarate

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 781

2022 Revenue in Millions : 837

Growth (%) : 6

blank

06

Brand Name : Takecab/Vocinti

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

Brand Name : Takecab/Vocinti

arrow
Pharma Summit
Not Confirmed

Vonoprazan Fumarate

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2024 Revenue in Millions : 868

2023 Revenue in Millions : 777

Growth (%) : 12

blank

07

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

08

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharma Summit
Not Confirmed

09

Brand Name : Takecab

Vonoprazan Fumarate

arrow
Pharmaceutical Sciences
Not Confirmed

Brand Name : Takecab

arrow
Pharmaceutical Sciences
Not Confirmed

Vonoprazan Fumarate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 518

2017 Revenue in Millions : 464

Growth (%) : 12%

blank